The National Health and Medical Research Council (NHMRC) – European Union (EU) Collaborative Research Grants scheme provides a contribution to Australian researchers participating in leading international collaborative research that has been favourably evaluated for funding under select European Commission Horizon 2020 topics.
Eligible Horizon 2020 topics for this round are:
- SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease.
- SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches.
- SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future.
- SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care.
- SC1-BHC-26-2018: HTA research to support evidence-based healthcare.
- SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals.
- SC1-DTH-03-2018: Adaptive smart working and living environments supporting active and healthy ageing.
- SC1-DTH-07-2018: Exploiting the full potential of in-silico medicine research for personalised diagnostics and therapies in cloud-based environments.
- SU-TDS-02-2018: Toolkit for assessing and reducing cyber risks in hospitals and care centres to protect data/infrastructures.
Note: More information about Horizon 2020 topics can be found by on the European Commission’s (EC) webpage.
Responsibility for submitting proposals to the EC under Horizon 2020 lies with the European partners.
Applications for the NHMRC – EU Collaborative Research Grants scheme are only required to be submitted to NHMRC if an application has been peer reviewed by the EC and is favourably evaluated for funding.
The Australian Chief Investigator A (CIA) must forward evidence that the application has been favourably evaluated, with their application, to the NHMRC by the closing date.